Saturday, October 18, 2025

Latest

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market yesterday under the symbol “DICE”. The firm’s initial public offering is looking to raise US$204.0 million and is expected to close on September 17, 2021.

The offering will be conducted through the issuance of 12.0 million common shares selling at US$17.00 per share. This is an adjustment from the company’s original plan to issue 10.0 million shares with share price expectations between US$15.00 and US$17.00.

The company granted the underwriters a 30-day over-allotment option to purchase additional 1.8 million common shares at the same IPO price, potentially bringing proceeds up to US$82.8 million. BofA Securities, SVB Leerink, and Evercore ISI are all acting as joint bookrunners for the said offering.

The California-based biotech firm is in the business of developing immunotherapies for patients with chronic diseases. Currently, the firm’s lead therapeutic candidate S011806 is an oral antagonist targeting a pro-inflammatory signaling molecule connected with a variety of immunology indications. The orally-available candidate is expected to enter its phase 1 trial in the second half of 2021.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

DWAC CEO-Advised Telco SPAC Nubia Brand International Prices US$110 Million IPO

Special purpose acquisition company Nubia Brand International Corp. (Nasdaq: NUBIU) started trading its securities on...

Friday, March 11, 2022, 02:20:00 PM

Ex-Sony Entertainment CEO-Led Gaming SPAC PowerUp Acquisition Prices Upsized US$250 Million IPO

Special purpose acquisition company PowerUp Acquisition Corp (Nasdaq: PWUPU) started trading publicly on the Nasdaq...

Friday, February 18, 2022, 02:26:00 PM

Accounts Payable Software AvidXchange Prices US$660 Million IPO

Accounts payable automation software AvidXchange Holdings, Inc. (Nasdaq: AVDX) started publicly trading on the Nasdaq...

Wednesday, October 13, 2021, 02:13:00 PM

Birkenstock Files For $8 Billion IPO

Birkenstock, the renowned German footwear company, took a significant step towards going public on Tuesday....

Wednesday, September 13, 2023, 10:36:00 AM

Wellness Firm The Better Being Co. Launches US$213 Million IPO

Whole-body wellness enterprise The Better Being Co. announced today the launch of its initial public...

Monday, July 26, 2021, 11:30:00 AM